What we need to know before chemotherapy and radiotherapy

There are now many different approaches to the treatment of cancer, each with differing advantages and disadvantages. Chemotherapy and radiotherapy are two common front line treatments. With respect to chemotherapy, studies have shown that about 25% of patients die or have a shortened life because of this treatment. This talk focuses on factors that should be considered to ensure that these treatments are as safe and effective as possible for each patient.

About about Peter

Peter was born in the UK but moved to Western Australia where he gained his PhD on immuno-genetics and went on to found the first Molecular Pathology laboratory in Western Australia. During that time, he conducted world-class research into tissue regeneration, genetics and epigenetics, cancer biology and molecular genetic aspects of cancer diagnosis. Peter and his PhD candidates published 93 papers in world-class scientific journals.

Peter returned to the UK over a decade ago and established an information service for cancer patients and practitioners. He notes that many patients are unaware of basic information that would help them to understand more about the development and progression of cancer and the pros and cons of various standards and new treatments. Peter is also part of the Health Sciences Academy team and contributes to their educational programme. Read more: https://thehealthsciencesacademy.org/research-team/

He may be contacted via email at peterhkay@gmail.com